Article
Functional correction of the untreatable CFTR 1717-1G>A mutation through mRNA- and sgRNA-optimized base editing.
Science translational medicine - 22 Apr 2026
Umbach Alessandro, Santini Annalisa, Bulcaen Mattijs, Guidone Daniela, Maule Giulia, Arosio Daniele, Carrozzo Irene, Ciciani Matteo, Brugnara Enrica, Ramalho Anabela, Vermeulen François, Galietta Luis J V, Carlon Marianne S, Cereseto Anna
Abstract excerpt
The 1717-1G>A is a prevalent splicing mutation causing cystic fibrosis (CF) for which no pharmacological treatments have been approved. This mutation disrupts a canonical 3' AG splice acceptor site in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leading to severe RNA missplicing, which prevents the correct synthesis of the encoded protein. In this study, we developed an adenine base...
Topics
Join the communities discussing this publication.
